Unknown

Dataset Information

0

ASH Highlights and Commentary: Multiple Myeloma

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC8974701 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown ASH Highlights and Commentary: Additional Topics of Interest
| S-EPMC8092335 | biostudies-literature
Unknown Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast.
| S-EPMC10329949 | biostudies-literature
Unknown Targeting BCMA to Treat Multiple Myeloma: Updates From the 2021 ASH Annual Meeting.
| S-EPMC8936073 | biostudies-literature
Unknown The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma.
| S-EPMC7804406 | biostudies-literature
Unknown Magic year for multiple myeloma therapeutics: Key takeaways from the ASH 2015 annual meeting.
| S-EPMC5354697 | biostudies-literature
Unknown Bispecific antibody treatment of multiple myeloma: latest updates from the 2022 ASH annual meeting.
| S-EPMC10657518 | biostudies-literature
Unknown Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma: latest updates from 2022 ASH Annual Meeting.
| S-EPMC10240779 | biostudies-literature
Unknown Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.
| S-EPMC6092251 | biostudies-literature
Unknown Highlights From the 2020 Virtual Advances in Inflammatory Bowel Diseases Conference: Commentary.
| S-EPMC8191823 | biostudies-literature
Genomics Multiple myeloma
| PRJNA515992 | ENA